UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000016619
Receipt number R000019293
Scientific Title A Feasibility Study of Gemcitabin and Bevacizumab in patients with Platinum-Resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Date of disclosure of the study information 2015/03/01
Last modified on 2016/11/15 10:28:26

No. Disposal Last modified on Item of update
1 Insert 2015/02/24 14:07:32
2 Update 2016/11/15 10:25:43 Key inclusion criteria
3 Update 2016/11/15 10:28:26 Name of primary person or sponsor
Organization